News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mount Sinai School of Medicine and Medisyn Technologies, Inc. Announce Agreement to Discover Novel Therapeutics for Treating Alzheimer's Disease


9/13/2007 10:49:04 AM

NEW YORK & MINNEAPOLIS--(BUSINESS WIRE)--Mount Sinai School of Medicine (MSSM) and Medisyn Technologies today announced a collaboration for the development of novel ß-amyloid (Aß) lowering drugs as a treatment in Alzheimer’s disease. Starting with MSSM’s previous research data obtained from testing early-stage lead compounds, the collaboration utilizes Medisyn Technologies’ molecular topology Forward Engineering™ platform to build a diverse pipeline of Alzheimer’s disease drug candidates. The goal of the study is to complete in vivo efficacy validation of the novel drug candidates by the end of 2007.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES